← FDA DRUG APPROVALS

FDA NDA · NDA208135

TETRACAINE HYDROCHLORIDE

Sponsor: ALCON LABS

APPLICATION
NDA208135
TYPE
NDA
ORIGINAL APPROVAL
2016-02-29
LATEST ACTION
2022-02-28
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

TETRACAINE HYDROCHLORIDE · ReferencePrescription
TETRACAINE HYDROCHLORIDE 0.5% · SOLUTION · OPHTHALMIC

Approval history

2022-02-28Labeling · Supplement 5 · standard — Letter ↗AP
2016-02-29Type 7 - Drug Already Marketed without Approved NDA · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →